Eriko Aimono

Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy

Kimiharu Takamatsu, Nobuyuki Tanaka, Kyohei Hakozaki et al. · Nature Communications · 2021 · 66 citations · Full text

Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer

Tsukasa Masuda, Nobuyuki Tanaka, Kimiharu Takamatsu et al. · Journal for ImmunoTherapy of Cancer · 2022 · 62 citations · Full text

Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumors

Keitaro Shimozaki, Hideyuki Hayashi, Shigeki Tanishima et al. · Scientific Reports · 2021 · 53 citations · Full text

The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan

Kuniko Sunami, Yoichi Naito, Eriko Aimono et al. · International Journal of Clinical Oncology · 2021 · 40 citations · Full text

ARID1A mutation/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancer

Yuka Kuroda, Tatsuyuki Chiyoda, Miho Kawaida et al. · Gynecologic Oncology · 2021 · 39 citations

Oncology, Somatic Variant, Medicine +9